MNKD MannKind Corporation

1.42
+0.14  (11%)
Previous Close 1.28
Open 1.34
Price To book 0.00
Market Cap 143.43M
Shares 101,006,000
Volume 6,002,031
Short Ratio 16.20
Av. Daily Volume 3,455,410

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved June 27, 2014.
AFREZZA
Type 1/2 diabetes

Latest News

  1. Short Sellers Raise the Stakes in Major Biotechs
  2. Edited Transcript of MNKD earnings conference call or presentation 10-May-17 9:00pm GMT
  3. Here's Why MannKind Corporation Stock Is Tanking Today
  4. Implied Volatility Surging for MannKind Corporation (MNKD) Stock Options
  5. Today's Research Reports on Stocks to Watch: MannKind and Neuralstem
  6. MannKind reports 1Q loss
  7. MannKind Corporation Reports 2017 First Quarter Financial Results
  8. Investor Network: MannKind Corporation to Host Earnings Call
  9. Today's on Research Reports on Biotech Stocks to Watch: TherapeuticsMD and MannKind
  10. MannKind Jumps After Amazon Prime Takes on One Drop
  11. MannKind and One Drop to collaborate on delivering better health outcomes for people with diabetes
  12. MannKind Corporation to Hold 2017 First Quarter Financial Results Conference Call on May 10, 2017
  13. Today's Research Reports on Biotech Stocks to Watch: Soligenix and MannKind
  14. Is MannKind Corporation Getting Ready to Sell?
  15. Sometimes Your Smartest Investing Move Is to Remain on the Sidelines
  16. Conatus Pharmaceuticals and MannKind Look Forward to Promoting Their Brand
  17. 3 Companies That Might Not Live to See 2020
  18. Billionaires' Worst Healthcare Stock Picks for 2017 (So Far)
  19. Could MannKind Corporation's Marketing Blitz Pay Off?
  20. Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now